Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation

被引：32
|
作者：
Montiel-Duarte, Cristina [1 ]
Cordeu, Lucia [1 ]
Agirre, Xabier [1 ]
Roman-Gomez, Jose [2 ]
Jimenez-Velasco, Antonio [3 ]
Jose-Eneriz, Edurne San [1 ]
Garate, Leire [1 ]
Andreu, Enrique J. [1 ]
Calasanz, Maria Jose [4 ]
Heiniger, Anabel [3 ]
Torres, Antonio [2 ]
Prosper, Felipe [1 ]
机构：
[1] Univ Navarra, Serv Hematol, Clin Univ, Div Canc,Area Terapia Celular,Fdn Appl Med Res, Navarra 31008, Spain
[2] Hosp Reina Sofia, Dept Hematol, Cordoba, Spain
[3] Hosp Carlos Haya, Dept Hematol, Malaga, Spain
[4] Univ Navarra, Sch Sci, Dept Genet, E-31080 Pamplona, Spain
来源：
LEUKEMIA RESEARCH | 2008年 / 32卷 / 05期
关键词：
PTEN; Ph+ ALL; Imatinib; PI3K AKT;
D O I：
10.1016/j.leukres.2007.09.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The aim of our study was to determine the potential mechanism(s) implicated in Imatinib resistance in patients with Ph+ ALL. Resistance of Ph+ ALL cells to Imatinib-induced apoptosis was associated with lack of inhibition of Akt phosphorylation. Addition of the PI3K inhibitor LY294002 to Imatinib significantly increased apoptosis of Ph+ ALL cells. Interestingly, expression of PTEN was reduced in Ph+ ALL cells which was due to PTEN promoter hypermethylation. Treatment of Ph+ ALL cells with 5-Aza-2'-deoxycytidine was associated with an increased expression of PTEN and an increase in cell apoptosis. These results suggest that Imatinib resistance in patients with ALL may be dependent at least in part to PTEN down-regulation due to the abnormal promoter hypermethylation and support the potential role of de-methylating agents for the treatment of patients with Ph+ ALL. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：709 / 716
页数：8
相关论文
共 50 条
  • [21] Imatinib mesylate-induced complete cytogenetic response in acute myeloid leukemia with t(5;12)(q33;p13).
    Blum, William
    Marcucci, Guido
    Devine, Hollie
    Klisovic, Rebecca
    BLOOD, 2006, 108 (11) : 181B - 181B
  • [22] PML/RARα mediates resistance to apoptosis and down-regulation of the NF-κB pathway in acute promyelocytic leukemia.
    Garcia-Casado, Z
    Cervera, J
    Pajuelo, JC
    Valencia, A
    Garcia, C
    Martin, G
    Bolufer, P
    Barragan, E
    Ballester, S
    Oltra, JS
    Martinez, N
    Marty, ML
    Piris, MA
    Sanz, MA
    BLOOD, 2004, 104 (11) : 155B - 155B
  • [23] Bone marrow necrosis associated with the use of imatinib mesylate in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Kosei Matsue
    Masami Takeuchi
    Mihoko Koseki
    Hidetaka Uryu
    Annals of Hematology, 2006, 85 : 542 - 544
  • [24] Bone marrow necrosis associated with the use of imatinib mesylate in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Matsue, Kosei
    Takeuchi, Masami
    Koseki, Mihoko
    Uryu, Hidetaka
    ANNALS OF HEMATOLOGY, 2006, 85 (08) : 542 - 544
  • [25] Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation
    Dellorto, Marta Campo
    Banelli, Barbara
    Giarin, Emanuela
    Accordi, Benedetta
    Trentin, Luca
    Romani, Massimo
    te Kronnie, Geertruy
    Basso, Giuseppe
    ONCOLOGY REPORTS, 2007, 18 (02) : 417 - 423
  • [26] Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region
    Ortmann, CA
    Burchert, A
    Hölzle, K
    Nitsche, A
    Wittig, B
    Neubauer, A
    Schmidt, M
    NUCLEIC ACIDS RESEARCH, 2005, 33 (21) : 6895 - 6905
  • [27] Human papillomavirus-positivity is associated with EREG down-regulation and promoter hypermethylation in head and neck squamous cell carcinoma
    Khanal, Sujita
    Strickley, John D.
    Thinh Ha
    Demehri, Shadmehr
    Ghim, Shin-Je
    Jenson, Alfred B.
    Redman, Rebecca A.
    Joh, Joongho J.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2020, 117
  • [28] Promoter hypermethylation-induced transcriptional down-regulation of the gene MYCT1in laryngeal squamous cell carcinoma
    Min Yang
    Wei Li
    Yi-Ying Liu
    Shuang Fu
    Guang-Bin Qiu
    Kai-Lai Sun
    Wei-Neng Fu
    BMC Cancer, 12
  • [29] Promoter hypermethylation-induced transcriptional down-regulation of the gene MYCT1 in laryngeal squamous cell carcinoma
    Yang, Min
    Li, Wei
    Liu, Yi-Ying
    Fu, Shuang
    Qiu, Guang-Bin
    Sun, Kai-Lai
    Fu, Wei-Neng
    BMC CANCER, 2012, 12
  • [30] Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia
    Holleman, A
    den Boer, ML
    Kazemier, KM
    Janka-Schaub, GE
    Pieters, R
    BLOOD, 2003, 102 (13) : 4541 - 4546
12345